Table 1. Clinico-pathological characteristics of the patients with ovarian tumors.
| Patient population | USC | UM | KCCRI | |||
|---|---|---|---|---|---|---|
| Patients’ number | 89 | 192 | 134 | |||
| Tumor type | Serous | 35(39.3%) | Serous | 152(79.2%) | Serous | 51(38.1%) |
| Endometrioid | 17(19.1%) | Endometrioid | 1(0.5%) | Endometrioid | 18(13.4%) | |
| Clear Cell | 10(11.2%) | Clear Cell | 3(1.6%) | Clear Cell | 38(28.4%) | |
| Mucinous | 17(19.1%) | Mucinous | 0(0%) | Mucinous | 15(11.2%) | |
| Rare subtype or low grade ovarian cancer | 5(5.6%) | Rare subtype or low grade ovarian cancer | 2(1.0%) | Rare subtype or low grade ovarian cancer | 2(1.5%) | |
| Other | 5(5.6%) | Other | 10(5.2%) | other | 9(6.7%) | |
| Mixed ovarian cancer* | 24(12.5%) | |||||
| Stage | Benign | 8(9.0%) | Benign | 18(9.5%) | Benign | 1(0.7%) |
| Stage I | 36(40.4%) | Stage I | 9(4.8%) | Stage I | 56(41.8%) | |
| Stage II | 6(6.7%) | Stage II | 17(9%) | Stage II | 16(11.9%) | |
| Stage III | 31(34.8%) | Stage III | 112(59.3%) | Stage III | 40(29.9%) | |
| Stage IV | 8(9.0%) | Stage IV | 30(15.9%) | Stage IV | 16(11.9%) | |
| Not known** | 3(1.6%) | Not known** | 5(3.7%) | |||
| Grade | Grade 0 | 1(1.1%) | Benign | 18(9.5%) | ||
| LMP | 13(14.6%) | Grade 1 | 19(10.1%) | |||
| Benign | 8(9.0%) | Grade 2 | 4(2.2%) | |||
| Grade 1 | 19(21.3%) | Grade 3 | 134(70.9%) | |||
| Grade 2 | 6(6.7%) | Not known** | 14(7.4%) | |||
| Grade 3 | 42(47.1%) | |||||
| Type of Chemotherapy | No chemotherapy | 31(34.8%) | No chemotherapy | 6(4.5%) | ||
| Platinum containing | 5(5.6%) | Platinum containing | 3(2.2%) | |||
| Platinum and taxol containing | 53(59.5%) | Platinum and taxol containing | 107(79.9%) | |||
| No Information | 18(13.4%) | |||||
| Race | Asian | 20(22.5%) | ||||
| Black | 2(2.2%) | |||||
| Native American | 3(3.3%) | |||||
| White | 64(71.9%) | |||||
*Mixed ovarian cancer (serous-endometrioids/serous-clear cell carcinoma/ endometrioids-clear cell carcinoma);**Not known (Either it was not clinically determinable or the data was not available).